Stem cell pathologies and neurological disease

Modern Pathology

Volumn 25, Issue 2, 2012, Pages 157-162

  Steindler, Dennis A ^a   Okun, Michael S ^b   Scheffler, Björn ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

brain tumor; neurodegenerative disease; regeneration failure; stem cell

Indexed keywords

BIOLOGICAL MARKER;

BRAIN TUMOR; DEGENERATIVE DISEASE; GLIOMA; HUMAN; HUNTINGTON CHOREA; NEURAL STEM CELL; NEUROLOGIC DISEASE; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; STEM CELL; STROKE;

EID: 84856537031     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.165     Document Type: Review

References (42)

1. Steindler DA, Pincus DW. Stem cells and neuropoiesis in the adult human brain. Lancet 2002;359:1047-1054. (Pubitemid 34286548)
2. Yamanaka S. Strategies and new developments in the generation of patient-specific pleuripotent stem cells. Cell Stem Cell 2007;1:39-49. (Pubitemid 46865811)
3. Cohen DE, Melton D. Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet 2011;12:243-252.
4. Burt RK, Loh Y, Cohen B, et al. Autologous nonmyeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 2009;8:244-253.
5. Conti L, Cattaneo E. Neural stem cell systems: physiological players or in vitro entities. Nat Rev Neurosci 2010;11:176-187.
6. Curtis MA, Faull RL, Eriksson PS. The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci 2007a;8:712-723. (Pubitemid 47283148)
7. Curtis MA, Eriksson PS, Faull RL. Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia. Clin Exp Pharmacol Physiol 2007b;34:528-532. (Pubitemid 46494484)
8. Curtis MA, Penney EB, Pearson AG, et al. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci USA 2003;100:9023-9027. (Pubitemid 36899216)
9. Arvidsson A, Collin T, Kirik D, et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002;8:963-970. (Pubitemid 35033700)
10. Lie DC, Dziewczapolski G, Willhoite AR, et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 2002;22:6639-6649. (Pubitemid 35386420)
11. Kordower JH, Chu Y, Hauser RA, et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008;14:504-506. (Pubitemid 351655212)
12. Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501-503. (Pubitemid 351655211)
13. Mendez I, Viñ uela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med. 2008;14:507-509. (Pubitemid 351655215)
14. Olanow CW, Prusiner SB. Is Parkinson's disease a prion disorder? Proc Natl Acad Sci USA 2009;106: 12571-12572.
15. Angot E, Steiner JA, Hansen C, et al. Are synucleinopathies prion-like disorders? Lancet Neurol 2010;9: 1128-1138.
16. Hansen C, Angot E, Bergström AL, et al. a-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011;121:715-725.
17. Emmanouilidou E, Melachroinou K, Roumeliotis T, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010;30:6838-6851.
18. Alvarez-Erviti L, Seow Y, Schapira AH, et al. Lysosomal dysfunction increases exosome-mediated alphasynuclein release and transmission. Neurobiol Dis 2011;42:360-367.
19. Cicchetti F, Saporta S, Hauser RA, et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci USA 2009;106:12483-12488.
20. Laywell ED, Bartsch U, Dorries U, et al. Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sci USA 1992;89:2634-2638.
21. Silver D, Steindler DA. Common astrocytic programs during brain development, injury and cancer. Trends Neurosci 2009;32:303-311.
22. Walton NM, Kobeissy F, Scheffler B, et al. Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation. Stem Cells 2009; 27:280-289.
23. Passegue E, Jamieson CH, Ailles LE, et al. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003;100:S1:11842-S1:11849.
24. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872. (Pubitemid 350138099)
25. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
26. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-545. (Pubitemid 34288856)
27. Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature 2002;416:545-548. (Pubitemid 34288857)
28. Chen KA, Cruz PE, Lanuto DJ, et al. Cell fusion for gene delivery to SCA1 affected Purkinje neurons. Mol Cell Neurosci 2011;47:61-70.
29. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-556.
30. Buffo A, Rite I, Tripathi P, et al. Origin and progeny of reactive gliosis: A sourece of multipotent cells in the injured brain. Proc Natl Acad Sci USA 2008;105: 3581-3586. (Pubitemid 351723595)
31. Skog J, Wü rdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-1476.
32. Zhao T, Zhang Z-N, Rong Z, et al. Immunogenecity of induced pluripotent stem cells. Nature 2011;474:212-215.
33. Bae KM, Su Z, Wang S, et al. Expression of pluripotent stem cell reprogramming factors by prostate tumorinitiating cells. J Urol 2010;183:2045-2053.
34. Hu BY, Weick JP, Yu J, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010;107:4335-4340.
35. Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471:68-62.
36. Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-67.
37. Walton NM, Sutter BM, Chen HX, et al. Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain. Development 2006;133:3671-3681. (Pubitemid 44614289)
38. Ignatova TN, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206.
39. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008;134: 877-886.
40. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136:964-977.
41. Thomas LB, Gates D, O'Brien TF, et al. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 1995;133: 265-272.
42. Kandasamy M, Couillard-Despres S, Raber KA, et al. Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease. J Neuropathol Exp Neurol. 2010; 69:717-728.